TherapeuticsMD (TXMD) Liabilities from Discontinued Operations (2010 - 2026)

TherapeuticsMD has reported Liabilities from Discontinued Operations for 7 years, with the latest figure at 2667000.0 in Q1 2026.

• For the quarter ending Q1 2026, Liabilities from Discontinued Operations fell 4.24% year-over-year to 2667000.0; the trailing twelve-month figure through Mar 2026 stood at 2667000.0 (down 4.24% YoY), and the FY2025 full-year result was 2667000.0, down 4.1% from the prior year.
• Liabilities from Discontinued Operations for Q1 2026 stood at 2667000.0, roughly flat from 2667000.0 in the prior quarter.
• The five-year high for Liabilities from Discontinued Operations was 25831000.0 in Q4 2022, with the low at 1372000.0 in Q2 2023.
• Historically, Liabilities from Discontinued Operations has averaged 4925928.57 across 5 years, with a median of 2783000.0 in 2024.
• Annual changes were most pronounced in 2023 — Liabilities from Discontinued Operations slumped 85.7% — and 2024, when it soared 138.45%.
• TherapeuticsMD's Liabilities from Discontinued Operations stood at 25831000.0 in 2022, then tumbled by 85.7% to 3694000.0 in 2023, then declined by 24.72% to 2781000.0 in 2024, then decreased by 4.1% to 2667000.0 in 2025, then changed by 0.0% to 2667000.0 in 2026.
• The last three Liabilities from Discontinued Operations figures came in at 2667000.0 (Q1 2026), 2667000.0 (Q4 2025), and 2667000.0 (Q3 2025), per Business Quant data.